StocktoriaAdvanced Biomed Inc. ADVB
Nasdaq · XNAS · stock · Services-Medical Laboratories
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Financials | ||
| Net income | -$3.3M | -$2.8M |
| Operating cash flow | -$5.8M | -$2.1M |
| Free cash flow | -$5.9M | -$2.2M |
| Total assets | $13.7M | $4.5M |
| Total liabilities | $10.2M | $2.8M |
| Shareholders' equity | $3.5M | $1.7M |
| Ratios | ||
| Return on assets | -23.8% | -62.4% |
| Return on equity | -93.7% | -167.3% |
| Current ratio | 1.31 | 1.12 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001941029 · as of 2025-06-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.